FindTrial
Sign In

Comparison of two intrarticular injections (dextrose versus autologus blood) in temporomandibular joint disorders

Comparison of role of Autologous Platelet rich plasma and dextrose prolotherapy in chronic degenerative disorders of temporomandibular joint: A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017056
Enrollment
20
Registered
2019-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M199- Osteoarthritis, unspecified site

Interventions

Intervention1: DEXTROSE: 2 ml of 12.5% dextrose is to be injected in joint, If partial relief is there then repeat injections is given at interval of 3 weeks and 6 weeks Control Intervention1: AUTOLO

Sponsors

All India Institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with internal derrangement of TMJ with pain, joint sounds and restricted mouth opening

Exclusion criteria

Exclusion criteria: 1. patients with myofascial pain dysfunction syndrome 2. immunocompromised patients 3. patients with platelet disorders or who have taken NSAIDS in past one week or those who have undergone corticosteroid injection intra articular in last two months

Design outcomes

Primary

MeasureTime frame
comparison of efficiency of PRP and dextrose in relieving TMD symptomsTimepoint: follow up weekly for 1 month and then at 2,4 and 6 months—

Secondary

MeasureTime frame
COMPLICATIONS ASSOCIATEDTimepoint: follow up weekly for 1 month and then at 2, 4 and 6 months—

Countries

India

Contacts

Public ContactDr Ankita Chugh

All India Institute of Medical Sciences,Jodhpur, Rajasthan

chugha@aiimsjodhpur.edu.in08003996891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026